Thrombocytosis and hyperkalemia associated with the use of ticarcillin/clavulanic acid.
D000328:Adult; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D010406:Penicillins / Q000009:adverse effects*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013922:Thrombocytosis / Q000139:chemically induced*; D013982:Ticarcillin / Q000009:adverse effects* / Q000627:therapeutic use
D002969:Clavulanic Acids; D010406:Penicillins; D019818:Clavulanic Acid; D013982:Ticarcillin